Search

You searched for "AMM"

2049 results found
Seminars in Ophthalmology journal cover image

Treat-and-extend regimen in treatment of patients with type 3 neovascularisation

5 October 2020 | | EYE - Vitreo-Retinal
Type 3 neovascularisation, also known as retinal angiomatous proliferation is a distinct subtype of neovascular AMD characterised by intraretinal neovascularisation. This retrospective study included 17 eyes diagnosed with type 3 neovascularisation who were changed from pro-re-nata (PRN) based treatment regime...
Seminars in Ophthalmology journal cover image

Intravitreal Ziv-Aflibercept: safety analysis

7 December 2020 | | EYE - Vitreo-Retinal
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...

The meaning of life

1 December 2021 | | EYE - Vitreo-Retinal, EYE - General
Supercomputer: “The answer to the great question of Life, the Universe and Everything is…”Programmer: “Yes…?”Supercomputer: “42. It was a tough assignment”.Programmer: “42? Is that all you have got to show for seven and a half million years work?” In this...

Cutting-edge practice in glaucoma care: what, how and why?

1 April 2016 | | EYE - Glaucoma
More effective treatments and drug delivery modalities, implantable minimally invasive glaucoma surgical (MIGS) devices, as well as accelerating clinical research programmes, will transform the surgical and clinical management of glaucoma in the near future. There is also an ever-greater emphasis...

Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board

6 December 2024 | research, education, KOL, glaucoma, innovation, treatment
Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...

OSA Sustainability Committee holds first meeting

4 August 2021
The OSA Sustainability Committee held its first meeting on Friday 23 July. The aim of the committee is to provide information, support and advice to OSA members who want to demonstrate their commitment to behaving in a more environmentally sensitive and more sustainable way.

ANZGS Congress 2026

13 February 2026 -15 February 2026
"As Chair of the Australian and New Zealand Glaucoma Society I am pleased to invite you to the 2026 ANZGS Congress which will be held in Sydney from 13 – 15 February 2026. The 2025 ANZGS Congress was held in...

Specialty-driven EMR for paperless clinical environment – insights for an informed choice

1 August 2016 | | EYE - General
Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...

What can artificial intelligence do to improve sustainability in the delivery of ophthalmic care?

1 December 2025 | | sustainability, artificial intelligence, technology
The 2025 NHS 10-year plan, titled ‘Fit for the Future’, emphasises a significant shift from analogue to digital, with a strong focus on integrating AI and other technologies to transform healthcare. The plan aims to make the NHS the "most...

Introducing the Interest in Ophthalmology Association

15 December 2025 | education, training, foundation year, professional development, research
We are very excited to announce the launch of Interest in Ophthalmology Association (InOA), a brand-new organisation to unite and support all those interested in eye health and vision sciences, starting in 2026! What is InOA? The InOA is a...

Twenty-five years in retina

1 February 2019 | | EYE - Vitreo-Retinal, EYE - General
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...